Ocugen (OCGN) Current Deferred Revenue (2014 - 2018)
Ocugen (OCGN) reported Current Deferred Revenue of $45000.0 for Q4 2018, up 28.57% on a YoY basis from $35000.0 in Q4 2017, and down 99.1% quarter-over-quarter from $5.0 million in Q3 2018.
Ocugen (OCGN) Current Deferred Revenue (2014 - 2018) Analysis & Trends
Ocugen has reported Current Deferred Revenue for 5 years, with the latest figure at $45000.0 in Q4 2018.
- For the quarter ending Q4 2018, Current Deferred Revenue rose 28.57% year-over-year to $45000.0; the trailing twelve-month figure through Dec 2018 stood at $45000.0 (up 28.57% YoY), and the FY2018 full-year result was $45000.0, up 28.57% from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $45000.0, down from $5.0 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $5.0 million in Q3 2018, with the low at $35000.0 in Q4 2017.
- Historically, Current Deferred Revenue has averaged $469647.1 across 5 years, with a median of $131000.0 in 2016.
- Annual changes were most pronounced in 2017 — Current Deferred Revenue slumped 91.4% — and 2018, when it jumped 8233.33%.
- Ocugen's Current Deferred Revenue stood at $219000.0 in 2014, then jumped by 85.84% to $407000.0 in 2015, then changed by 0.0% to $407000.0 in 2016, then tumbled by 91.4% to $35000.0 in 2017, then gained by 28.57% to $45000.0 in 2018.
- The last three Current Deferred Revenue figures came in at $45000.0 (Q4 2018), $5.0 million (Q3 2018), and $40000.0 (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 45,000.00 |
| Sep 30, 2018 | 5.00 Mn |
| Jun 30, 2018 | 40,000.00 |
| Mar 31, 2018 | 37,000.00 |
| Dec 31, 2017 | 35,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 86,000.00 |
| Mar 31, 2017 | 110,000.00 |
| Dec 31, 2016 | 407,000.00 |
| Sep 30, 2016 | 133,000.00 |
| Jun 30, 2016 | 131,000.00 |
| Mar 31, 2016 | 128,000.00 |
| Dec 31, 2015 | 407,000.00 |
| Sep 30, 2015 | 225,000.00 |
| Jun 30, 2015 | 407,000.00 |
| Mar 31, 2015 | 514,000.00 |
| Dec 31, 2014 | 219,000.00 |